Seiichi Okamura

Chuo, 8108563, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Generalised granuloma annulare associated with myelodysplastic syndrome.

Generalised granuloma annulare associated with myelodysplastic syndrome.

Journal: European journal of dermatology : EJD

Published: May 24, 2016

Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.

Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.

Journal: Virchows Archiv : an international journal of pathology

Published: May 03, 2016

High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma, Similar to 2 Other CD8+ T-Cell Lymphomas.

High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma, Similar to 2 Other CD8+ T-Cell Lymphomas.

Journal: The American journal of surgical pathology

Published: January 28, 2016

Clinicopathological Features and Outcome of Lung Cancer Patients with Hematological Malignancy.

Clinicopathological Features and Outcome of Lung Cancer Patients with Hematological Malignancy.

Journal: Annals of surgical oncology

Published: August 15, 2015

Prophylaxis against Pneumocystis jirovecii pneumonia in patients with adult T-cell lymphoma/leukemia receiving anti-CC chemokine receptor 4 monoclonal antibody.

Prophylaxis against Pneumocystis jirovecii pneumonia in patients with adult T-cell lymphoma/leukemia receiving anti-CC chemokine receptor 4 monoclonal antibody.

Journal: The Journal of infection

Published: August 05, 2015

Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics.

Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics.

Journal: Annals of hematology

Published: September 05, 2014

Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.

Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.

Journal: Histopathology

Published: July 30, 2014

UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan.

UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan.

Journal: Annals of hematology

Published: March 16, 2014

MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review.

MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review.

Journal: Japanese journal of radiology

Published: April 02, 2013

Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.

Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.

Journal: Virchows Archiv : an international journal of pathology

Published: November 27, 2012

Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups.

Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups.

Journal: International journal of hematology

Published: September 06, 2012

Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine

Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: August 21, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026